Booz Allen acquires analytics start-up Epidemico

Laura Pedulli | | Health Exec | Digital Transformation

Booz Allen Hamilton has purchased Epidemico, a Boston-based health analytics start-up, for an undisclosed amount, reports The Washington Post.

Epidemico is the creator of HealthMap, an online mapping tool that tracks the spread of diseases using a computer algorithm. It has been credited with tracking Ebola in West Africa before the World Health Organization declared it an outbreak.

Read more below:

Booz Allen buys Boston health analytics start-up Epidemico

Laura Pedulli

Related Content

10 signs AI is ‘eating the world (of venture capital)’
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024
Providers, payers share actionable experiences involving healthcare AI

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.